Pharma & Finance Consulting SRL
Pharma & Finance Consulting reported total assets of 42,184 € at the end of the 2025 financial year (annual accounts filed with the NBB on 30 Jun 2026).
The score of Pharma & Finance Consulting shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +76 % Total assets -10 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Pharma & Finance Consulting's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 30 Jun 2026
- Year ended 31 Dec 2024filed on 30 Jun 2025
- Year ended 31 Dec 2023filed on 19 Jul 2024
Pharma & Finance Consulting's financial analysis
- Solvency79.1%sector median: 58.4%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Pharma & Finance Consulting
Pharma & Finance Consulting's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0791.674.606
- VAT number
- BE0791674606
- Peppol
- Registered · 0208:0791674606 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 30 Sep 2022
- Registered office
- 2340 Beerse
- Latest accounts
- 2025 · filed on 30 Jun 2026
- Activity
- Business and other management consultancy activities (NACE 70200)
Pharma & Finance Consulting (SRL) has been based in Beerse since 2022, active in: business and other management consultancy activities. For 2025, it reports a net profit of 6,378 € and equity of 33,385 €; its revenue is not published. Its solvency stands at 79.1%, above the median of its sector (58.4%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to Pharma & Finance Consulting
Companies in the same business, of comparable size and area, outside its group.
- Fineuro Consulting Business and other management consultancy activities Tournai · balance sheet 171,629 €
- Regulus Europe Business and other management consultancy activities Zoersel · balance sheet 49,412 €
- Cela Consulting Business and other management consultancy activities Molenbeek-Saint-Jean · balance sheet 190,572 €
- CXB Business and other management consultancy activities Tongeren-Borgloon · balance sheet 49,795 €
- Norconsulting Belgium Business and other management consultancy activities Etterbeek · balance sheet 43,481 €
- Verleyen Consulting Business and other management consultancy activities Woluwe-Saint-Pierre · balance sheet 56,970 €
- B-Ascend Consulting Business and other management consultancy activities Lasne · balance sheet 37,279 €
- Agora STSL Business and other management consultancy activities Auderghem · balance sheet 62,340 €
Frequently asked questions about Pharma & Finance Consulting
What is the revenue of Pharma & Finance Consulting?
Pharma & Finance Consulting files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Pharma & Finance Consulting?
In Belgium, the VAT number is the company number prefixed with BE: BE0791674606 for Pharma & Finance Consulting, if the company is VAT-registered. Its company number (CBE) is 0791.674.606.
Where is the registered office of Pharma & Finance Consulting?
According to the CBE register, the registered office of Pharma & Finance Consulting is in 2340 Beerse.
What is the equity of Pharma & Finance Consulting?
At the close of the 2025 financial year, the equity of Pharma & Finance Consulting amounts to 33,385 €, a solvency of 79.1% of total assets.
Who manages Pharma & Finance Consulting?
The register lists 1 active mandates at Pharma & Finance Consulting. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Pharma & Finance Consulting
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →